Verve Therapeutics
VERV
#5985
Rank
NZ$1.71 B
Marketcap
NZ$19.24
Share price
0.00%
Change (1 day)
124.27%
Change (1 year)

Earnings for Verve Therapeutics (VERV)

Earnings in 2025 (TTM): -NZ$0.36 Billion

According to Verve Therapeutics's latest financial reports the company's current earnings are NZ$59.61 Million. In 2024 the company made an earning of -NZ$0.4 Billion a decrease over its 2023 earnings that were of -NZ$0.39 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Verve Therapeutics from 2020 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$0.36 Billion-11.39%
2024 -NZ$0.4 Billion2.48%
2023 -NZ$0.39 Billion34.67%
2022 -NZ$0.29 Billion90.3%
2021 -NZ$0.16 Billion114.31%
2020 -NZ$70.22 Million